New analysis from Frost & Sullivan (http://www.medtech.frost.com), Market Trends in Europe Interventional Radiology and Cardiology, finds that the market earned approximately $336.7 million in 2012 and estimates this to reach $352.6 million in 2016. Novel applications, the demand for hybrid solutions and the need for new systems in Eastern Europe will fuel market growth.
One of the key trends in medicine is the steady replacement of open surgeries with minimally invasive procedures. Hybrid operating rooms support this trend.
“The expansion of minimally invasive procedures and hybrid operating rooms are set to galvanise the interventional radiology and cardiology markets,” notes Frost & Sullivan’s Healthcare Industry Analyst Dominika Grzywinska. “Minimally invasive procedures are becoming increasingly popular, among both patients and healthcare providers. This has spurred the demand for hybrid operating rooms accommodating interventional systems.”
Hybrid systems combine operating room equipment with large diagnostic units and can be used by a variety of medical specialties. A mid-term obstacle could potentially be the high cost of such hybrid solutions. Nevertheless, an increasing number of healthcare facilities are investing in such models, as they offer a significant competitive advantage, and with appropriate throughput, a positive return on investment.
The economic slump had a strong impact on revenues in 2012, particularly in the more mature markets of Western Europe, such as Italy and Spain. Confronted by economic uncertainty, many facilities decided to put their investments on hold, contributing to lower revenue generation.
“With approaching market saturation, especially in Western Europe, end users are increasingly interested in user-friendly, integrated solutions,” concludes Grzywinska. “Vendors need to offer customised solutions that meet the specific needs of end-users, rather than providing standard, ready-to-use ones.”
Market Trends in Europe Interventional Radiology and Cardiology is part of the Advanced Medical Technologies Growth Partnership Service programme. Frost & Sullivan’s related research services include: Medical Imaging Markets in Europe, Image-guided and Robot-assisted Surgery Markets in Western Europe, and Critical Care Solutions in Europe. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.